Molecular mechanisms for inhibition of colon cancer cells by combined epigenetic-modulating epigallocatechin gallate and sodium butyrate.

Authors:
Sabita N Saldanha
Sabita N Saldanha
University of Alabama at Birmingham
United States
Rishabh Kala
Rishabh Kala
1300 University Boulevard
United States
Trygve O Tollefsbol
Trygve O Tollefsbol
University of Alabama at Birmingham
Birmingham | United States

Exp Cell Res 2014 May 8;324(1):40-53. Epub 2014 Feb 8.

Department of Biology, University of Alabama at Birmingham, 175 Campbell Hall, 1300 University Boulevard, Birmingham, AL 35294, USA; Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA; Comprehensive Center for Healthy Aging, University of Alabama at Birmingham, Birmingham, AL 35294, USA; Nutrition Obesity Research Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA; Comprehensive Diabetes Research Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA. Electronic address:

Bioactive compounds are considered safe and have been shown to alter genetic and epigenetic profiles of tumor cells. However, many of these changes have been reported at molecular concentrations higher than physiologically achievable levels. We investigated the role of the combinatorial effects of epigallocatechin gallate (EGCG), a predominant polyphenol in green tea, and sodium butyrate (NaB), a dietary microbial fermentation product of fiber, in the regulation of survivin, which is an overexpressed anti-apoptotic protein in colon cancer cells. For the first time, our study showed that the combination treatment induced apoptosis and cell cycle arrest in RKO, HCT-116 and HT-29 colorectal cancer cells. This was found to be regulated by the decrease in HDAC1, DNMT1, survivin and HDAC activity in all three cell lines. A G2/M arrest was observed for RKO and HCT-116 cells, and G1 arrest for HT-29 colorectal cancer cells for combinatorial treatment. Further experimentation of the molecular mechanisms in RKO colorectal cancer (CRC) cells revealed a p53-dependent induction of p21 and an increase in nuclear factor kappa B (NF-κB)-p65. An increase in double strand breaks as determined by gamma-H2A histone family member X (γ-H2AX) protein levels and induction of histone H3 hyperacetylation was also observed with the combination treatment. Further, we observed a decrease in global CpG methylation. Taken together, these findings suggest that at low and physiologically achievable concentrations, combinatorial EGCG and NaB are effective in promoting apoptosis, inducing cell cycle arrest and DNA-damage in CRC cells.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.yexcr.2014.01.024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043227PMC

Still can't find the full text of the article?

We can help you send a request to the authors directly.
May 2014
72 Reads

Publication Analysis

Top Keywords

cancer cells
16
colorectal cancer
12
epigallocatechin gallate
8
combination treatment
8
cycle arrest
8
sodium butyrate
8
ht-29 colorectal
8
rko hct-116
8
cell cycle
8
crc cells
8
molecular mechanisms
8
cells
8
physiologically achievable
8
colon cancer
8
cancer
5
cells arrest
4
arrest ht-29
4
observed rko
4
cell lines
4
lines g2/m
4

Similar Publications